Skip to main content
Veterinary Medicines

Lincofort 400 400 mg/ g Proszek do sporządzania roztworu doustnego

Authorised
  • Lincomycin hydrochloride

Product identification

Medicine name:
Lincofort 400 400 mg/ g Proszek do sporządzania roztworu doustnego
Active substance:
  • Lincomycin hydrochloride
Target species:
  • Chicken (hen)
  • Pig
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    435.90
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (hen)
      • Meat and offal
        5
        day
    • Pig
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Biofaktor Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biofaktor Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2328
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."